Patients with Positive CI Findings
| Patient no. | Sex | Age (y) | H | PT | Stage | TCD (GBq) | TSH* on T4 | Tg† on T4 | TSH* off T4 | Tg† off T4 | CI findings (n) | FDG PET results (n) | Histopathology | FU TSH* | FU Tg† |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 70 | P | T4 | III | 7.4 | 1.5 | 950 | 170 | 2,700 | Lung on CT (+) | Lung (+) | Positive (B) | 0.8 | 800 (Ext rad) |
| 2 | M | 69 | P | T4 | III | 7.4 | 2.1 | 1,820 | 110 | 5,100 | Lung on CT (+) | Lung (+) | Positive (B) | 0.24 | 2,200 (Ext rad) |
| 3 | M | 60 | FC | T4 | III | 7.4 | 0.64 | 12 | 81 | 48 | Lung on CT (1) | Lung (2) | Positive (S) | 0.11 | <0.6 |
| 4 | F | 63 | FC | T4 | III | 14.8 | ND | 21 | >50 | 100 | Doubtful on CT | Lung (+), CLN (2) | ND | 0.6 | 50 (Ext rad) |
| 5 | F | 64 | HC | T4 | III | 3.7 | 0.01 | 869 | 141 | 6,000 | Lung on CT (+) | Lung (+), MLN (1) | Positive (B) | <0.01 | 1,783 |
| 6 | M | 78 | P | T4 | III | 7.4 | 0.11 | 29 | >50 | 176 | CLN on US, MRI (1) | CLN (3) | Positive (S) | ND | Deceased |
| 7 | M | 65 | HC | T3 | IV | 7.4 | 0.05 | 30 | 99 | 128 | Bone on BS, MRI (1) | Bone (1) | Positive (S) | <0.05 | 0.5 |
| 8 | F | 45 | P | T4 | III | 7.4 | 0.66 | 2.5 | >50 | 15 | CLN on US, CT (1) | CLN (1) | Positive (S) | 0.02 | <0.6 |
| 9 | M | 36 | P | T2 | I | 11.1 | 0.2 | 2 | >50 | 153 | CLN on US (1) | Negative | Positive (S) | 0.03 | <0.3 |
| 10 | M | 38 | P | T4 | I | 7.4 | <0.1 | 5.2 | >50 | 30 | CLN on US, CT (1) | CLN (2) | Positive (S) | 0.5 | <0.3 |
↵*Data in mU/L.
↵†Data in μg/L.
H = histology of thyroid carcinoma; PT = primary tumor stage; TCD = total cumulative dose; T4 = l-thyroxine; FU = follow-up; P = papillary carcinoma; + = multiple; B = biopsy; Ext rad = external radiation; FC = follicular carcinoma; S = surgery; ND = not done; CLN = cervical lymph node; HC = Hürthle-cell carcinoma; MLN = mediastinal lymph node; US = sonography; BS = bone scintigraphy.